Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Drug Evaluation × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 2 Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4 Breast 4 Lymphoid 2 Gynecologic 2 Dermatologic 2 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Genitourinary 1 Gastrointestinal 1 CNS 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 1263 Fluorouracil 1174 Capecitabine 959 Gemcitabine 923 Leucovorin 838 Irinotecan 733 Bevacizumab 710 Cisplatin 594 Radiotherapy 490 Cetuximab 414 pembrolizumab 382 Paclitaxel 348 Nivolumab 295 Drug Therapy 280 130-nm albumin-bound paclitaxel 279 Docetaxel 261 S 1 (combination) 251 Sorafenib 245 Folfox protocol 234 Albumin-Bound Paclitaxel 223 durvalumab 193 Surgical Procedures, Operative 185 apatinib 184 sintilimab 177 tislelizumab 176 lenvatinib 176 Radiosurgery 175 Carboplatin 165 Radiation 157 regorafenib 156

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00582660 2017-06-15

UAB0040

University of Alabama at Birmingham

Phase 2 Completed

40 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡